Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid ERRα overexpression further aggravates PAN-induced

ERRα overexpression further aggravates PAN-induced apoptosis

is a Hepatic Differentiation Inducer which is able to induce the differentiation of rat MSCs (rMSCs) toward hepatocyte-like cells in vitro

Ketanserin depresses and in certain experiments reverses the vasoconstrictor response to 5-hydroxytryptamine in the perfused guinea-pig stomach

Smiles: CC#CC(=O)N1CCC[C@H]1C1=NC(C2C=CC(=CC=2)C(=O)NC2=CC=CC=N2)=C2C(N)=NC=CN12

PMID: 32658637

Linifanib (ABT-869) - CAS# 796967-16-3 Size:10mg solid ERRα overexpression further aggravates PAN-inducedLinifanib, CAS No. 796967 16 3, also known as ABT 869, is an orally bioavailable, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. Linifanib inhibits members of the vascular endothelial growth factor (VEGF) and platelet derived growth factor (PDGF) receptor families; it exhibits much less activity against unrelated RTKs, soluble tyrosine kinases, or serine threonine kinases. This agent does not have a